Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Klautke, G; Brunner, TB.
Radiotherapy in pancreatic cancer.
Strahlenther Onkol. 2008; 184(11):557-64
Doi: 10.1007/s00066-008-1865-8
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Brunner Thomas Baptist
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- UNLABELLED: PURPOSE AND APPROACH: To summarize the current knowledge on the role of radiotherapy in the treatment of pancreatic ductal adenocarcinoma (PDAC). The results of meta-analyses, phase III-studies, and phase II-studies using chemoradiation (CRT) and chemotherapy for resectable and non-resectable PDAC are reviewed. RESULTS AND CONCLUSION: The role of CRT is undefined in the adjuvant setting but there may be a role as additive treatment after R1 resection. Locally advanced borderline resectable tumors may shrink down and be subject to potentially curative resections. In locally advanced clearly unresectable cancers the effect of CRT as well as chemotherapy is poorly defined and the sequence of chemotherapy and CRT should be re-evaluated. Patients with PDAC should always be treated within studies to identify optimal treatment results.
- Find related publications in this database (using NLM MeSH Indexing)
- Adenocarcinoma - mortality, pathology, radiotherapy, surgery
- Algorithms - administration & dosage
- Clinical Trials as Topic - administration & dosage
- Combined Modality Therapy - administration & dosage
- Europe - epidemiology
- Humans - administration & dosage
- Neoplasm Staging - administration & dosage
- Pancreatic Neoplasms - mortality, pathology, radiotherapy, surgery
- Treatment Outcome - administration & dosage
- Find related publications in this database (Keywords)
- Pancreatic cancer
- Chemoradiation
- Locally advanced
- Adjuvant
- Neoadjuvant